Although the aforementioned evidence collectively indicates the promotional effect of IL-17-producing Tregs on intestinal tumors, it is important to acknowledge that IL-17-producing Tregs can induce both pro-inflammatory reactions that promote tumorigenesis (pro-inflammatory properties) and immunosuppression that facilitates tumor evasion (immunosuppressive properties). The gene discussed is IL17A; the disease is intestinal neoplasm.